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Abstract: The present review discusses the functional and molecular diversity of GABA receptors. These receptors were 
originally described in the mammalian retina, and their functional role in the visual pathway has been recently elucidated; 
however new studies on their distribution in the brain and spinal cord have revealed that they are more spread than  
originally thought, and thus it will be important to determine their physiological contribution to the GABAergic trans- 
mission in other areas of the central nervous system. In addition, molecular modeling has revealed peculiar traits of  
these receptors that have impacted on the interpretations of the latest pharmacolgical and biophysical findings. Finally,  
sequencing of several vertebrate genomes has permitted a comparative analysis of the organization of the GABA genes. 
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DIVERSITY OF GABA RECEPTORS 
  GABA is one of the most important inhibitory neuro-
transmitters in the vertebrate central nervous system (CNS) 
and is involved in manifold physiological and pathological 
processes. As a molecule, it was first described in the early 
1900’s, whereas its presence in the CNS and its role as a 
neurotransmitter were recognized only in the 1950’s [1-4]. 
During the following two decades, numerous studies were 
done to determine the specific mechanism of action of 
GABA, and in the 1960’s firm evidence established its   
inhibitory role in the cerebral cortex [5]. It is estimated that 
GABA is the most abundant inhibitory neurotransmitter   
in the CNS; it is widely distributed in all major areas of   
the brain and participates in about 40% of the inhibitory   
synapses in adult vertebrates [6, 7]. 
  GABA exerts its actions through two different types of 
plasma membrane receptors: GABAA and GABAB, which 
have different pharmacological, structural, and molecular 
characteristics [8-10]. In the 1990´s the existence of a new 
class of GABAA receptor was reported: the GABA, and in 
this review we will discuss the molecular properties, tissue 
distribution and the structural genes coding for these 
GABA receptors. We will also present the evidence for 
their expression in the brain, a comparative analysis of their 
genomic structures, data derived from molecular modeling, 
and insight on their intracellular trafficking. 
  During the mid 1970’s several isolated reports described 
the existence of a type of GABA receptor that was insensi-
tive to bicuculline, which contrasted with the antagonistic 
effect of this alkaloid on classical GABAA receptors. This 
peculiar component was also found in several areas of the  
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CNS, including the cat spinal cord [11], frog optic tectum 
[12, 13], guinea pig superior colliculus [14], cerebellum, and 
rat cerebral cortex [15]. However, it was not until 1991 when 
expression of retinal mRNA in X. laevis oocytes clearly 
demonstrated the presence of an ionotropic GABA receptor, 
insensitive to bicuculline and resistant to baclofen [16].   
This new receptor was named GABA to denote its retinal 
origin. 
  The first subunit of this receptor family was cloned from 
a human retina cDNA library. The gene was named 
GABA1 [17], and it codes for a receptor that is abundant in 
the retina; when expressed in X. laevis oocytes it exhibited 
the same characteristics as the receptor found after injection 
of retinal mRNA. To denote the clear pharmacological and 
molecular properties of this receptor, a new family name was 
coined: the GABAC receptor, which comprised at that point 
the GABA1 subunit but eventually grew to a total of three 
subunits: GABA1, GABA2, and GABA3. Currently, the 
name GABAC is in disuse, and the three GABA genes are 
included in the GABAA receptor family (GABAA receptor, 
 subunits); they are part of the Cys-loop superfamily   
of neurotransmitter receptors, also called the ligand-gated 
ion-channel (LGIC), which includes the GABAA receptors, 
nicotinic acetylcholine receptors (nAChR), glycine receptors 
(GlyR), ionotropic 5-HT receptors (5HT3), and a Zn
2+-
activated ion channel [18].  
BASIC STRUCTURE, BIOPHYSICS, AND PHARMA-
COLOGY 
  Based on studies performed with other ionotropic recep-
tors and on electrophysiological evidence, it is thought that 
GABA subunits assemble into a pentamer that forms a Cl
- 
channel in its center. The general structure of every subunit 
consists of an extracellular amino terminal domain, four 
transmembrane domains, and an extracellular carboxy termi-
nus. The binding site of GABA is located in the extracellular 
amino-terminal domain that, upon activation, leads to the An Update on GABA Receptors  Current Neuropharmacology, 2010, Vol. 8, No. 4    423 
opening of the ion channel with the subsequent flux of Cl
- 
through it. 
  There are three very distinctive functional characteristics 
that are unique to the GABA receptor: long mean opening 
time of the channel, low conductance, and low rate of desen-
sitization and the mean open time of the channel ranges from 
150 to 200 ms, which is more than five-fold longer than that 
of other GABAA subunits [19-23]. 
  The conductance of the human GABA1 channel ranges 
between 0.6 and 1.6 pS, and is considerably smaller than 
other GABAA subunits [24]. Membrane noise analysis of the 
cloned GABA receptors of the white perch showed that the 
conductance of GABA1A is 0.2 pS, that of GABA2A is 
3.2 pS, and that of GABA2B is 3.5 pS [25]. It has been 
shown in X. laevis oocytes that after activation, GABA1 
keeps the channel conducting even after ten minutes or more 
of exposure to the agonist, and the magnitude of the response 
diminishes only 8 to 10% during this time. Furthermore, 
repetitive applications of the agonist do not lead to a dimin-
ished response to subsequent applications, in clear contrast 
with other types of ionotropic receptors [16, 26]. In the axon 
terminal of the retinal bipolar neurons of the goldfish, the 
conductance of the GABA receptor is 4 pS [27], and it is 8 
pS in the bipolar neurons of the rat [20]. In summary, the 
channel of the homomeric GABA receptors conducts for a 
longer time with respect to different heteromeric combina-
tions of the GABAA receptors, the main-state conductances 
are smaller, and have a lower rate of desensitization; how-
ever, we still have to characterize these properties for 
GABA3 receptors in the ganglion neurons of the retina   
and neurons in several other areas of the brain that express 
them.  
  One of the most relevant characteristics is the high sensi-
tivity to GABA, with an EC50 in the range of 0.8 to 2.2 μM 
for homomeric GABA1 and GABA2 recombinant recep-
tors [16, 21, 22, 28-30] and around 7.5 μM for homomeric 
GABA3 receptors [22], which is over five-fold more sensi-
tive than other GABAA subunits. In addition, GABAA cur-
rents on bipolar cells are rapid and transient, whereas 
GABA currents are slower and desensitize very little; fur-
thermore, GABA receptors also have much higher sensitiv-
ity to GABA than typical GABAA receptors in retinal bipolar 
cells [31]. 
  Four agents have been of great use for the study of 
GABA receptors due to their high selectivity. Cis-4-
aminocrotonic acid (CACA) and cis-2-aminomethyl cyclo-
propanocarboxylic acid (CAMP) are the most selective   
agonists for GABA receptors [32], whereas the 1, 2, 5, 6-
tetrahydropyridine-4 methylphosphinic acid (TPMPA) and 
3-aminocyclopentyl methylphosphinic acid [(±)-cis-3-
ACPMPA] are selective antagonists [33, 34]. Other antago-
nists reported to be highly specific for GABA1 are gua-
nidine-acetic acid, amino-cyclopent-1-enyl phosphinic acid, 
and 3-aminocyclobutane phosphinic acid [35, 33, 5], wher-
eras cyclothiazide blocks GABA2 [36]. Cis-and trans-(3-
aminocyclopentanyl) butylphosphinic acid are a new genera-
tion of conformationally restricted analogues that competi-
tively block GABA receptors and prevent the development 
of experimental myopia [37, 38]. In addition, these com-
pounds enhance learning and memory in rats, as assesed by 
the reduced time that the animals take to find the platform in 
the Morris water maze, which suggests a role for the receptor 
in cognitive processes. 
  The action of GABA on the GABA receptors is allos-
terically modulated by a wide variety of chemical entities 
which interact with distinct binding sites at the GABA recep-
tor complex [39, 40], either acting as inhibitors (Zn
2+, Ni
2+, 
Cd
2+) or potentiators (Ba
2+, Sr
2+) [41, 42]. The lanthanides 
potentiate the GABA receptors in the cloned GABA1  
receptor [41, 43].  
  Finally, the insensitivity to the GABAA receptor antago-
nist bicuculline, its resistance to the GABAB-receptor agonist 
baclofen [32, 35, 44, 45], and the lack of response to the 
GABAA-receptor modulators, such as benzodiazepines [32, 
46], barbiturates, and neurosteroids [32, 47] set apart this 
class of receptor. 
MOLECULAR MODELING 
  The Cys-loop receptors, a gene superfamily to which the 
ionotropic GABA receptors belong, have two conserved 
cysteines that form a disulfide bond [48]. Current under-
standing of the structural basis of how ionotropic Cys-loop 
receptors work is relatively advanced compared to other   
areas of ion channel biophysics [48-55]. Nevertheless, many 
questions remain, not only about biophysical properties but 
also about the structural basis for how these receptors affect 
cellular and systems physiology. 
  The best information about the molecular structure of the 
Cys-loop family comes from the nicotinic acetylcholine re-
ceptor (nAChR). This receptor forms heteropentameric com-
plexes [14, 56-60] that have dextrohelicoidal symmetry with 
respect to an axis at the midpoint of the ion pathway and a 
tilt angle of 10º [61]. The GABA receptors share three main 
domains with all the family members. The first one is the N-
terminal extracellular domain, which consists of 10 -sheets, 
2 -helices, and one 310-helix; it is very similar to the con-
formation of the immunoglobulin -sandwich domain and 
contains the agonist binding site and the Cys-loop. This do-
main also forms an extracellular ionic-preselection vestibule 
by means of the electrostatic potential confered by the recep-
tor surface that is accessible to the solvent [61].  
  The second main domain is the pore itself, composed of 
the second (M2) of four transmembrane -helices (M1–M4), 
whereas the remaining three (M1, M3, M4) form a “hydro-
phobic shelter”, protecting and incorporating the pore into 
the plasma membrane. The pore contains subdomains of 
functional importance, such as the “gate” associated with 
hydrophobic residues in the middle of an -helix which is 
structurally distorted when the receptor is activated, leading 
to global conformational changes, and the “selectivity filter” 
which is conferred by the electrostatic restriction of charged 
residues in the narrowest and most intracellular region of the 
channel [49, 61-63].  
 Each  transmembrane  -helix is connected with the next 
one through a loop; the third loop has an intracellular dispo-
sition and a variable length according to the subunit that 
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tant and confers several structural properties, such as key 
interactions with the cytoskeleton, anchoring and stabilizing 
the receptor, and determining its cellular location; it probably 
also affects the ion conductance. Finally, this loop forms 
another  -helix just before the M4 helix; this continued   
loop is called the MA helix and it forms an intracellular   
funnel-like structure which gives rise to a vestibule through 
which the ions are forced to enter the cell by way of the  
intersubunit window-like spaces [64]. 
  In constrast, the GABA receptor has proven to be diffi-
cult to overexpress and purify, and its structure has not been 
solved by high-resolution methods such as X-ray crystallog-
raphy or nuclear magnetic resonance (NMR) [65, 66]. Thus, 
the homology-based modeling currently gives the most accu-
rate and reliable structural model. It is based on the general 
observation that evolutionarily related (homologous) proteins 
are likely to have similar structures [67, 68]. We developed a 
model for the GABA receptor (Fig. 1), using the well-
known structure of the close homologue, nAChR from the 
Torpedo marmorata, and prokaryotic homologues such as 
the Erwinia chrysanthemi and Gleobacter violaceus [69, 70]. 
These models has helped us to design experiments to deter-
mine the functional role of amino acid residues of the M4 
domain [71], and it will be useful to understand the structural 
rearrangements generated by ligand binding which lead to 
the channel activation. 
  Binding and gating are mutually coupled in an allosteric 
way in the GABA1 receptor, in such a way that the binding 
for GABA appears strongly potentiate its affinity becoming 
virtually infinite, locking the agonist in the binding pocket. 
Channel gating thus produces broad conformational changes 
from the agonist binding pocket to the gating of the channel 
[30, 72]. A recent study has pointed out that the increase in 
agonist binding affinity and the channel opening do not oc-
cur simultaneously [73], but instead in two sequential steps: 
1) the distortion in the binding domain, and 2) the channel 
opening. There is an intermediate state, termed the “flip 
state”, with the receptor binding domain switching to a high 
affinity state before channel opening. This event is well de-
scribed by the Monod-Wyman-Changeux model of allosteric 
activation (MWC), suggesting strong similarity to the proc-
ess of enzymatic catalysis [74-76].  
  The structural model of the agonist binding pocket was 
further validated and extended when the high resolution 
structure of the acetylcholine binding protein (AchBP) was 
determined [77-81]. In addition, the functional connection 
between the agonist binding pocket and channel opening was 
defined by using as template the structures of bacterial 
homologues [69, 70, 82]. Thus, it has been determined that 
tilting of M2, dilation of the pore, and a quaternary twist of 
the five subuints, are the key events of channel gating [83]. 
There are five potential binding pockets on each of the five 
subunit interfaces of Cys-loop receptors, and the five tyro-
sine residues (Tyr102, Tyr198, Tyr200, Tyr241, and Tyr247) 
that play a central role in the binding site are conserved in 
GABA1 [84, 85]. It is stated that the GABA carboxylate 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Structural model of the GABA receptors. A) Ribbon diagram of a single GABA1 subunit viewed in the plane of the transmem-
brane domains, beginning at the N-terminus of the ribbon and finishing at the C-terminus. The extracellular -helix is labeled -1. 
The strands are labeled 1-10; the four transmembrane -helices (M1-M4), MA domains, and the cys-loop are highlighted. Dashed lines 
indicate the position of the plasma membrane. B) Transverse, and C) longitudinal representations of the GABA1 homopentameric complex, 
with respect to the plane of the plasma membrane, highlighting the main domains: extracellular domain (ECD), transmembrane domain 
(MD), intracellular domain (MA), and the ion pathway. An Update on GABA Receptors  Current Neuropharmacology, 2010, Vol. 8, No. 4    425 
group forms a salt bridge with Arg104, Ser168, Ser243, 
whereas its ammonium moiety is engaged in cation–  
interactions or forms a hydrogen bond with Tyr198 in the  
so-called ‘‘loop C’’ that connects -sheets 9 and 10 [44, 86, 
87].  
  To achieve the long-range communication that is funda-
mental to the Cys-loop receptor function, other extracellular 
domain residues must be involved in communicating the 
binding event to the channel gate, playing a crucial step in 
the gating pathway [88]. Different regions and residues of 
the Cys-loop receptor subunits are essential in channel   
gating: loops 12, 67, and 89 at the interface be-
tween the extracellular domain and transmembrane domains 
have been identified as constitutive transducers of the open-
ing signal from the agonist binding site to the transmembrane 
domain [55]. 
  However, in spite of these advances and understanding 
progressively more about the structural characteristics of the 
receptor, further experiments will be necessary to determine 
the precise, detailed mechanism of allosteric regulation, 
which may enable the design of drugs to palliate diseases 
involving GABA receptors. 
DISTRIBUTION IN THE CNS AND BEYOND 
 GABA receptors have been extensively studied in the 
retina of several species, where they are mainly expressed in 
bipolar and horizontal cells [25, 38, 89-92, 95]; at least one 
report shows their expression in photoreceptors [96], and for 
many years it was believed that their expression was limited 
to this structure of the nervous system. However, over the 
last several years evidence has accumulated showing that 
GABA receptors are, in fact, widely expressed, not only in 
the retina or areas related to the visual system but also in the 
peripheral nervous systems and even in the gastrointestinal, 
where the motor function within the myenteric plexus could 
be influenced by GABA activation of the inhibitory motor 
neurons. In the cardiovascular system GABA acts directly on 
cardiac function through GABA receptors located within the 
electrical conduction system cells [97], and in sperm cells 
are involved in the acrosome reaction [98]. 
  It is now known that GABA subunits are expressed in 
the brain cortex, thalamus, hippocampus, superior colliculus, 
cerebellum, and spinal cord [99-104], ventral and dorsal lat-
eral geniculate nuclei [105, 106], thyrotropin secreting cells 
of the pituitary [99, 107], the dorsolateral geniculate gyrus of 
the thalamus [108], and pretectal nucleus of the optic tract 
[109]. However, there are other areas of the CNS where their 
expression of GABA subunits remains to be determined or 
is puzzling.  
Retina 
  Numerous studies showed that GABA1 and GABA2 
were specifically expressed in the bipolar and horizontal 
cells of the retina, whereas GABA3 was found in the gan-
glion neurons [38, 89, 90, 92, 93, 95, 103, 110-114]. Further 
insight into the physiological role of these receptors in the 
retina was gained through the study of knock out mice for 
the GABA1 subunit [115, 116]. This subunit plays no role 
in retinal development since there was no evidence of ana-
tomical alterations in the retina when its expression was 
eliminated. However, its elimination leads to the total   
absence of GABA responses in the internal and external 
plexiform layers and a defect in the transmission of   
visual signals from bipolar neurons to third order neurons. 
This suggests that, at least in the retina, the expression   
of GABA1 is necessary for the appropriate functional 
modulation between bipolar and ganglionar cells [31, 117-
119]. Furthermore, it was recently reported that two forms of 
GABA-mediated inhibition exist in the terminals of bipolar 
cells and that they could be evoked by vesicular and by non-
vesicular GABA release. These forms of inhibition are inde-
pendently activated and regulated, which suggests a diversity 
of mechanisms that control the output signal of the bipolar 
cell terminals [119]. 
Midbrain and Superior Colliculus 
  The superfical layers of the mammalian superior collicu-
lus (SC) are involved in processing the visual information, 
and it is precisely in this area that GABA receptors are   
expressed [14, 120, 121]. GABAergic interneurons in the 
striatum gray superficiale (SGS) and pretectal nuclear com-
plex (PNC) have been found to express the receptor and 
GABA transporter 1 (GAT 1) [102, 122-124]. In situ hy-
bridization revealed GABA1 and GABA2 in the superfi-
cial gray layer of the rat SC [125, 126]. These findings have 
been confirmed by immunohistochemistry and electrophysi-
ology [102, 109, 125, 127, 128]. Furthermore, a punctate 
pattern of expression was found in the superficial gray layer, 
which suggests the synaptic localization of these receptors. 
Interestingly, an increase in neuronal excitability was ob-
served after the activation of GABA receptors in this struc-
ture [128], in contrast to their effects in the retinal bipolar 
neurons [112]. Finally, GABA2 seems to be of particular 
importance in the SC, because the knockout of GABA1 
does not eliminate GABA receptor responses there [129], 
whereas GABA responses are completely abolished in the 
retina [38]. By comparison to previously published data, this 
could indicate a fundamental difference between the retina 
and the SC in the rules that govern the expression and subunit 
composition of the GABA receptors. In the visual cortex, 
only the GABA2 subunit mRNA is expressed [102]. Finally, 
it has also been shown by in situ hybridization that GABA1 
and GABA2 are expressed in the Stratum opticum [121], 
optic nerve tract [99], and superficial gray layer [130]. 
Thalamus 
  Also considered to be related to the visual system [131], 
the thalamus expresses the GABA1 receptor [100], and 
they have been found in several nuclei. They were located in 
a subpopulation of cells in the dorsolateral geniculate nu-
cleus; the GABA subtype mediate 25% or more of the total 
current of the GABAergic ionotropic receptors predomi-
nantly, if not exclusively, expressed by local GABAergic 
interneurons [132]. GABA receptors are also expressed in 
neurons of the tectothalamic projection [121] and nucleus 
habenularis medialis [127]. 
Brain Cortex 
  There is very little information about GABA receptors 
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is well known and in general, the GABAergic system plays a 
major role in the inhibitory functions of the cerebral cortex, 
the expression of GABA receptors in this vast area of intri-
cate neuronal networks is not well understood. By RT-PCR 
it has been possible to identify the GABA2 subunit in the 
frontal, temporal, occipital, and parietal areas of the human 
cortex, whereas GABA1 was found only in the frontal and 
temporal cortex [100]. It has also been demonstrated by in-
situ hybridization in the rat brain cortex that GABA 
subunits are localized in the visual area of the occipital cor-
tex in layers I-III [104, 121]. However, there are no data to 
confirm these findings or give further insight into the cellular 
localization of these receptors in the cortex.  
Basal Ganglia 
  Evidence about the expression of GABA receptors in 
this structure is still limited. So far, the expression of 
GABA3 mRNA has been shown in rat [94] and of 
GABA1 and GABA2 in bovine striatum, and potential 
alternatively spliced variants of the GABA1 subunit were 
identified in this species [133, 134]. The presence of 
GABA in the basal ganglia is an interesting result, since the 
GABAergic system in this region is well known to be in-
volved in movement control, and GABA receptors were 
found in spiny pyramidal neurons of the dorsal caudate pu-
tamen [134]. However, the electrophysiological responses to 
GABA in this structure are consistent with the more common 
GABAA receptors [58]. Further research will be necessary to 
clarify the expression and precise cellular localization of 
GABA subunits and in addition, it would be necessary to 
explain the lack of GABA receptor-like currents. One pos-
sibility could be a co-assembly of GABA with GABAA 
subunits [8, 95, 135, 136], which would mask the typical 
GABA pharmacology, but such complexes have not yet 
been reported in this area of the brain. 
Pituitary 
  Evidence of the expression of GABA1, GABA2, and 
GABA3 has been found in the pituitary of rat and guinea 
pig, including localization in somatrophs, gonadrops, and in 
an adenoma cell line (GH3) that was derived from this gland 
[99, 107, 133]. Interestingly, the GABA currents found in 
TSH cells are insensitive to bicuculline and resistant to ba-
clofen, but they desensitize rapidly like a classic GABAA 
receptor [99]. Other evidence suggests a specific role of 
GABA receptors in the facilitation of prolactin secretion 
from anterior pituitary cells [137].  
Cerebellum 
  One of the first clues to the existence of GABA recep-
tors was obtained from binding studies with tritriated ba-
clofen and GABA, which showed the presence of GABA 
and CACA sites that are insensitive to bicuculine and resis-
tant to baclofen [138]. Later on, GABA1 and GABA2 
were detected in human cerebellum with higher expression 
of GABA2 [127, 100]. Finally, GABA13 mRNAs 
subunits and GABA-like currents were reported in X. laevis 
oocytes injected with mRNA of cerebellar cortex [139], in 
agreement with previous evidence for the presence of mRNA 
in the Purkinje cell line and basket cells [103, 133], where  
a role for GABA receptors in the phasic inhibition at   
interneuron-Purkinje cell synapses has been suggested [140].  
Brain Stem and Spinal Cord 
  There is clear evidence  for  the expression of GABA 
receptors in the spinal cord and brain stem as well as their 
co-assembly with other GABAA subunits [45, 99, 120, 133, 
141, 142], which suggests the formation by GABAA and 
GABA of functional, heteromeric receptors [120, 135, 
134]. These studies also indicate that the mRNA of GABA 
receptors is more abundant in the spinal cord than in the 
brainstem.  
Corpus Callosum 
  There is little evidence supporting the expression of 
GABA receptors in the comissures, where the population of 
neurons is very low and the main cell types are neuroglia. 
The expression of GABA1 mRNA was demonstrated [133]; 
however, its function has not been proved, and GABA cur-
rents reported in several studies show only the classic 
GABAA component [143].  
Hippocampus 
  Initially, the expression of GABA receptors in this area 
was suggested by the transient expression of a bicuculline-
insensitive, GABA-gated Cl
- channel during early develop-
ment [144]. Later on, several studies reported the localiza-
tion and electrophysiological expression of GABA recep-
tors from both neurons in culture and slices of pyramidal and 
granule cells of hippocampus [99, 101, 106, 145-148]. Re-
cent reports have suggested that activated GABA receptors 
help to protect against neurotoxicity in hippocampal cultures 
[149]. 
Amygdala 
 GABA receptors have been detected in several areas of 
the amygdala, including the lateral, basolateral, and central 
nuclei [150, 151]. Likewise, it has been reported postsynaptic 
GABA receptors in this area [152]. Neurons in the lateral 
division of the central amygdala have two types of fast   
inhibitory synapses with either GABAA or GABA receptors 
but targeted to spatially and functionally distinct synapses 
[152]. Recordings in the lateral division of central amygdala 
showed miniature inhibitory postsynaptic currents (mIPSC) 
with small amplitude and slow rise-time whose frequency 
indicated the presence of GABA receptors [153]. 
Invertebrates 
  Ionotropic GABA receptors described in invertebrates 
have characteristics that do not fit completely with those of 
vertebrate GABA receptors. The GABA-gated cation chan-
nel EXP-1, cloned from C. elegans [154], belongs to the 
LGIC superfamily and exhibits sequence homology to the 
Drosophila LCCH3 and GRD subunits. Interestingly, the Rdl 
(resistant to dieldrin) subunit of Drosophila displays 43 % 
homology at the amino acid level to the rat GABA1 subunit 
[155], but the functional and pharmacological characteristics 
are quite different. Analysis of the Drosophila  gene se-
quences predicts one additional candidate, AAF48539 [156], 
and one more was predicted in the genome of one cnidarian 
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to date, no invertebrate receptor subunit has been character-
ized as a clear homolog of vertebrate GABA.  
GENOMIC STRUCTURE OF THE GABA GENES 
AND INSIGHT INTO THEIR EVOLUTION 
  Completion of the sequence of several vertebrate   
genomes, including human and chimpanzee as well as other 
organisms such as the tunicate Ciona intestinalis, allowed 
defining the distribution and the intron-exon structure of   
the genes coding for ionotropic GABA-receptor subunits. 
Mapping and sequencing of GABAA subunit genes showed 
that they are organized in gene clusters composed of , , 
and  subunit genes [68, 158-161]. It is generally considered 
that the evolution of the myriad of genes encoding for 
GABAA receptors comprised a number of events in the early 
evolution of the chordate lineage: first, a whole-genome du-
plication gave rise to the loci in at least two chromosomes; 
this was followed by a tandem duplication of an -subunit 
gene, after which a second whole-genome duplication   
occurred [162]. These events could account both for the   
multiple isoforms of , , and  subunits as well as for their 
localization in different chromosomes [158, 161].  
 The  GABA coding-genes are considered to be very 
closely related to the GABAA- and Glycine-receptor genes 
(about 40% nucleotide sequence homology), and it has been 
proposed that the two families share a common ancestor 
[162]. However, the evolutionary history and structural or-
ganization of the genes encoding the three GABA subunits 
has been little explored [159, 163].  
  Two of the three genes encoding for GABA subunits 
(GABA1 and GABA2) are located on chromosome 6q14-
q21 of the human genome [163], whereas GABA3 is found 
on chromosome 3q11-q13 [159]. DNA sequence compari-
sons among several completed genome sequences allowed us 
to determine the localization of GABA genes and several 
other GABA-like loci. The exon-intron composition of 
these genes, as predicted by computer analysis of intron-
exon boundaries, is shown in Fig. (2). The DNA coding se-
quence homology between human GABA subunits and 
other vertebrates ranges from 82% for the fish Morone 
americana to 99% for chimpanzee Pan troglodytes.  
  The chromosome localization of the GABA genes 
within the genomes of higher vertebrates is clearly syntenic 
and matches their human and murine distribution: GABA1 
and GABA2 are found as a single cluster, whereas 
GABA3 is located on a different chromosome.  
  Analysis of the genomic sequence of the tunicate C.  
intestinalis [164], revealed a GABA-like gene on chromo-
some 4. Although a full functional analysis of the structural 
gene is necessary, as well as of the receptor itself, it is clear 
that this gene is closely related to the GABA subunits 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Comparison of the exon and intron structure of GABA genes. Relative positions of the coding and non-coding sequences are 
shown to scale. Exons are illustrated in red for all the genes. Notice the compact structure of the C. intestinalis GABA- like gene. 428    Current Neuropharmacology, 2010, Vol. 8, No. 4  Martínez-Delgado et al. 
[165]. We could not identify a second GABA-like gene, 
and an exhaustive search is needed in this and other tunicates 
in order to reconcile this observation with the hypothesis of 
the timing of the first vertebrate genome duplication that is 
thought to have occurred after the divergence of the tunicates 
and prior to the appearance of the jawed fish [166, 167]. 
  Another interesting feature about the comparison of 
GABA genes is their structural variation among different 
phylogenetic lineages. The number of exons for the three 
genes is generally between 8 and 10; however, two interest-
ing exceptions occur: 1) the predicted number of exons for 
GABA2 of Pan troglodytes is 16, whereas the human gene 
has only 8. Nevertheless, the nucleotide sequences of the 
coding regions are 99% identical for the two species. The 
unique distribution and number of exons in the chimpanzee 
GABA2 raises the possible existence of splicing isoforms 
of its mRNAs. 2) An extreme example of a radically differ-
ent gene structure is that of Gallus gallus. In this species, the 
number of exons is 21 for GABA1, whereas GABA2 and 
GABA3 have 12 and 7, respectively.  
  Despite all the differences in the gene structure of 
GABA receptors, it is worth mentioning that the amino acid 
sequence of the three receptors is highly conserved among 
the different taxa evaluated here. With its ancient origin, C. 
intestinalis represents the most divergent amino acid se-
quence of all chordates, about 40% homologous to the hu-
man GABA1.  
  The cluster-organization of genes may be of developmen-
tal and physiological relevance, contributing to their time- 
and cell-specific expression. Support for this idea is provided 
by the coordinated expression of GABA1 and GABA2 
during early retinal development, where both subunit genes 
are transcriptionally active in the bipolar neurons at postnatal 
day 9, whereas GABA3 is expressed in a population of 
ganglion neurons [111, 141]. Based on the genomic ar-
rangement of GABA genes, future experimental approaches 
will define the role of the cluster organization within the 
transcription regulatory context as well as the possible impli-
cations of the exon/intron composition of the genes in gener-
ating mRNA variants. Furthermore, sequence analysis of the 
upstream regions of each gene could suggest conserved mo-
tifs important for their expression in the retina. 
SUBCELLULAR DISTRIBUTION 
  The precise location of the receptor channels in the syn-
aptic cleft is a determinant for them to play their essential 
role in transmitting the synaptic impulse. The GABA recep-
tors have been detected in the synaptic axon terminal of the 
bipolar neuron of the retina [90, 31, 93, 27, 114, 168]. Here, 
they modulate the surround and lateral inhibition [169]. We 
do not yet know how the receptor reaches this terminal end, 
and we have ignored the cellular and molecular components 
that dictate the trafficking of the receptor from its point of 
translation and towards the axon terminal. 
  Numerous interactions within the synapse organization 
regulate protein localization [170, 171], mediating the proper 
clustering and anchoring of receptors to the cytoskeleton. For 
some years, it has been proposed that GABA receptors as-
sociate with the Microtubule-Associated Protein 1B 
(MAP1B) through the interaction with the second intracellu-
lar loop of the GABA1 subunit [172]. In contrast, Meixner 
[173] showed that disruption of MAP1B is not a crucial ele-
ment in the expression and localization of the receptor. Con-
troversy emerged once again when Billups [174] demon-
strated the association of MAP-1B with two key residues 
(KY) in the large intracellular loop of GABA1, and showed 
that this interaction modulates the mean open-time and kinet-
ics of the channel.  
  Those contrasting observations are not definitive and the 
saga will continue until precise experiments define the asso-
ciation between GABA receptors and cytoskeleton. On the 
other hand, an interaction proposed between GABA1 and 
the cellular retinoic acid receptor could serve as a link be-
tween the GABA signaling pathway and the control of gene 
expression in neurons [175]; however, this has not been 
proven experimentally. 
  Receptors tagged with fluorescent labels will certainly be 
major tools to determine associations between the GABA 
and molecular and cellular components and to follow the 
trafficking of receptors in the neuron [176-178]. Likewise, 
the fact that the trafficking of the receptor may be actually 
visualized by using real time fluorescence microscopy from 
the site of protein translation to its final destination at the 
plasma membrane could shed some light on the dynamics 
and mechanisms that control receptor recycling. Many of 
these processes are currently being explored for GABAA 
receptors [179, 180]. 
 Since  GABA receptor trafficking may be an important 
control point for regulating cell and network activity in the 
SNC and retina, new experimental approaches will help to 
answer emerging questions such as: What are the mecha-
nisms involved in the liberation and/or selective retention 
that contribute to maintaining the dynamics and polarized 
distribution of the GABA receptors in neurons? Is the en-
docytic system a station of direct distribution versus libera-
tion and/or is there a necessary step for the accumulation of 
the receptors, as well as of a new population of receptors 
expressed de novo? Is the distribution of receptors mediated 
by the differential distribution of proteins of membrane 
and/or cytoskeleton in the different neuronal compartments? 
PERSPECTIVES 
  More studies are necessary to determine the precise dis-
tribution of GABA receptors in the central and peripheral 
nervous systems as well as in other organs and systems 
where they are expressed, such as the heart, the liver and the 
gastrointestinal tract [52, 99, 181]. We already know the 
location of the receptor in bipolar neurons of the retina, but 
future studies will disclose the cellular localization and func-
tion of the GABA receptors in other areas of the CNS such 
as the caudate nucleus, bulb, cerebellum, pons, and corpus 
callosum. The possible expression and role of alternatively 
spliced variants of these receptors in different areas of the 
CNS must also be examined [26, 99, 109, 133]. 
  All of the evidence regarding the widespread distribution 
of GABA receptors suggests that they may be involved in 
more functions than previously thought, and we still have to An Update on GABA Receptors  Current Neuropharmacology, 2010, Vol. 8, No. 4    429 
determine their physiological relevance. For example, it has 
been shown that TPMPA, the selective antagonist of 
GABA receptors, increases both quiet and active waking, 
decreases total slow-wave sleep essentially by decreasing the 
slow-wave stage, and also decreases paradoxical sleep [9]. In 
the hippocampus, these receptors could also have a role in 
memory processes, as already suggested by some experi-
ments [107]. According to the findings of several studies that 
located GABA receptors in areas such as spinal cord moto-
neurons, Purkinje cells of the cerebellar cortex, bulb, pons 
and caudate nucleus, they could also play an important role 
in movement control [103, 133]. Furthermore, the expression 
of GABA receptors in the amygdala [73, 182] and its pos-
sible correlation with anxiety should be considered. Altera-
tions of GABA-signaling have been associated with alcohol 
dependence, and a recent study revealed single nucleotide 
polymorphisms in GABA2 that is associated with this de-
pendance [183].  
  One of the most interesting developments on GABA 
receptors research is the possible therapeutic applications 
that these receptors may have. In a model of hepatic en-
cephalopathy that affects hippocampal neurons, the stimula-
tion of GABA receptors reduces ammonia-induced accu-
mulation of Cl
-, leading to decreased hyperexcitability [147]. 
More recently, it has been described an association of poly-
morphisms in the GABA2 gene with serum creatinine lev-
els, an important biomarker for assessment of kidney func-
tion [184], thus proposing a potential role of GABA recep-
tors in the regulation of renal function. These are only a few 
of many potential regulatory roles of GABA receptors and 
its participation in different physiological processes [10, 58, 
83, 97, 98, 132, 152, 181, 183-188]. On the other hand,   
expression mediated by adenovirus of GABA receptors 
suppressed neuronal hyperexcitability and the associated 
neuronal death [189] and therefore, virus-mediated neuronal 
GABA receptor expression offers a potential therapeutic 
tool for directly inhibiting hyperexcited neurons responsible 
for clinical problems, thereby avoiding the generalized nerv-
ous system depression associated with pharmacological ther-
apy [189]. Thus, it will be important to know the precise 
regulatory mechanism that activates the expression of the 
receptor in the proper cell types. Furthermore, the potential 
of adenovirus to express tagged receptors in living cells   
may allow the tracking of the localization and dynamics 
[189, 190]. 
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